Show simple item record

dc.contributor.authorHua, Chia-Ho
dc.contributor.authorMascia, Anthony E.
dc.contributor.authorSeravalli, Enrica
dc.contributor.authorLomax, Antony J.
dc.contributor.authorSeiersen, Klaus
dc.contributor.authorUlin, Kenneth
dc.date2022-08-11T08:08:27.000
dc.date.accessioned2022-08-23T15:55:38Z
dc.date.available2022-08-23T15:55:38Z
dc.date.issued2021-05-01
dc.date.submitted2021-06-21
dc.identifier.citation<p>Hua CH, Mascia AE, Seravalli E, Lomax AJ, Seiersen K, Ulin K. Advances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives. Pediatr Blood Cancer. 2021 May;68 Suppl 2(Suppl 2):e28344. doi: 10.1002/pbc.28344. PMID: 33818892; PMCID: PMC8030241. <a href="https://doi.org/10.1002/pbc.28344">Link to article on publisher's site</a></p>
dc.identifier.issn1545-5009 (Linking)
dc.identifier.doi10.1002/pbc.28344
dc.identifier.pmid33818892
dc.identifier.urihttp://hdl.handle.net/20.500.14038/29799
dc.description.abstractOver the last two decades, rapid technological advances have dramatically changed radiation delivery to children with cancer, enabling improved normal-tissue sparing. This article describes recent advances in photon and proton therapy technologies, image-guided patient positioning, motion management, and adaptive therapy that are relevant to pediatric cancer patients. For medical physicists who are at the forefront of realizing the promise of technology, challenges remain with respect to ensuring patient safety as new technologies are implemented with increasing treatment complexity. The contributions of medical physicists to meeting these challenges in daily practice, in the conduct of clinical trials, and in pediatric oncology cooperative groups are highlighted. Representing the perspective of the physics committees of the Children's Oncology Group (COG) and the European Society for Paediatric Oncology (SIOP Europe), this paper provides recommendations regarding the safe delivery of pediatric radiotherapy. Emerging innovations are highlighted to encourage pediatric applications with a view to maximizing the therapeutic ratio.
dc.language.isoen_US
dc.relation<p><a href="http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=pubmed&cmd=Retrieve&list_uids=33818892&dopt=Abstract">Link to Article in PubMed</a></p>
dc.relation.urlhttps://doi.org/10.1002/pbc.28344
dc.subjectCOG
dc.subjectSIOP
dc.subjectmedical physicist
dc.subjectpediatric cancer
dc.subjectradiation therapy
dc.subjectNeoplasms
dc.subjectOncology
dc.subjectPediatrics
dc.subjectRadiation Medicine
dc.titleAdvances in radiotherapy technology for pediatric cancer patients and roles of medical physicists: COG and SIOP Europe perspectives
dc.typeJournal Article
dc.source.journaltitlePediatric blood and cancer
dc.source.volume68 Suppl 2
dc.identifier.legacycoverpagehttps://escholarship.umassmed.edu/faculty_pubs/2009
dc.identifier.contextkey23450641
html.description.abstract<p>Over the last two decades, rapid technological advances have dramatically changed radiation delivery to children with cancer, enabling improved normal-tissue sparing. This article describes recent advances in photon and proton therapy technologies, image-guided patient positioning, motion management, and adaptive therapy that are relevant to pediatric cancer patients. For medical physicists who are at the forefront of realizing the promise of technology, challenges remain with respect to ensuring patient safety as new technologies are implemented with increasing treatment complexity. The contributions of medical physicists to meeting these challenges in daily practice, in the conduct of clinical trials, and in pediatric oncology cooperative groups are highlighted. Representing the perspective of the physics committees of the Children's Oncology Group (COG) and the European Society for Paediatric Oncology (SIOP Europe), this paper provides recommendations regarding the safe delivery of pediatric radiotherapy. Emerging innovations are highlighted to encourage pediatric applications with a view to maximizing the therapeutic ratio.</p>
dc.identifier.submissionpathfaculty_pubs/2009
dc.contributor.departmentDepartment of Radiation Oncology
dc.source.pagese28344


This item appears in the following Collection(s)

Show simple item record